5HPP-33
SIGMA/H9415 - ≥98% (HPLC), solid
Synonym: 2-
CAS Number: 105624-86-0
Empirical Formula (Hill Notation): C20H21NO3
Molecular Weight: 323.39
MDL Number: MFCD03085294
Linear Formula: C20H21NO3
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts H9415-25MG.
This image depicts H9415-25MG.
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | solid |
| InChI | 1S/C20H21NO3/c1-11(2)14-6 |
| InChI key | LAKWINYVWJPHQW-UHFFFAOYSA |
| Quality Level | 100  |
| SMILES string | CC(C)c1cccc(C(C)C)c1N2C(= |
| solubility | DMSO: >20 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | 5HPP-33 is a thalidomide derivative which was reported to be active as anticancer agent through stabilization of the microtubules. |
| Biochem/physiol Actions: | 5HPP-33 is a thalidomide derivative which was reported to be active as anticancer agent through stabilization of the microtubules. 5HPP-33 has shown inhibition of cell proliferation of both estrogen-dependent (MCF-7) and estrogen-independent (MDA-MB-231) breast cancer cells as well as other cell lines. A study in tubulin forming assay reported that 5HPP-33 acts as a microtubule formation inhibitor (IC50=810 nM). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |  GHS09 |
| Signal word | Warning |
| Hazard statements | H410 |
| Precautionary statements | P273 - P501 |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |